Liguori, C.; Copparoni, C.; Felicetti, C.; Pecci, F.; Lupi, A.; Pinterpe, G.; Berardi, R.; Giampieri, R.
Hemoglobin and Neutrophil Count as Prognostic Factors in Cholangiocarcinoma Patients in 2nd Line Treatment Setting: Results from a Small Monocentric Retrospective Study. Curr. Oncol. 2023, 30, 1032-1045.
https://doi.org/10.3390/curroncol30010079
AMA Style
Liguori C, Copparoni C, Felicetti C, Pecci F, Lupi A, Pinterpe G, Berardi R, Giampieri R.
Hemoglobin and Neutrophil Count as Prognostic Factors in Cholangiocarcinoma Patients in 2nd Line Treatment Setting: Results from a Small Monocentric Retrospective Study. Current Oncology. 2023; 30(1):1032-1045.
https://doi.org/10.3390/curroncol30010079
Chicago/Turabian Style
Liguori, Carolina, Cecilia Copparoni, Cristiano Felicetti, Federica Pecci, Alessio Lupi, Giada Pinterpe, Rossana Berardi, and Riccardo Giampieri.
2023. "Hemoglobin and Neutrophil Count as Prognostic Factors in Cholangiocarcinoma Patients in 2nd Line Treatment Setting: Results from a Small Monocentric Retrospective Study" Current Oncology 30, no. 1: 1032-1045.
https://doi.org/10.3390/curroncol30010079
APA Style
Liguori, C., Copparoni, C., Felicetti, C., Pecci, F., Lupi, A., Pinterpe, G., Berardi, R., & Giampieri, R.
(2023). Hemoglobin and Neutrophil Count as Prognostic Factors in Cholangiocarcinoma Patients in 2nd Line Treatment Setting: Results from a Small Monocentric Retrospective Study. Current Oncology, 30(1), 1032-1045.
https://doi.org/10.3390/curroncol30010079
